Skip to main content

Increased Isoprostane 8-epi-PGF2A in Statin-Induced Myopathy

  • Chapter
  • 85 Accesses

Part of the book series: Medical Science Symposia Series ((MSSS,volume 16))

Abstract

The most prevalent side effect of statins are muscle pains occurring in presence but also in absence [1] of elevated creatine phosphokinase (CK). In one patient statin-induced muscular pains improved significantly after vitamin E [2]. Thereafter, examining another patient we found for the first time a pronounced increase in 8-epi-PGF, disappearing after withdrawal of the respective statin. Earlier it has been reported that rhabdomyolysis is associated with an increase in isoprostane (IP) formation [3]. Therefore, we assessed the IP 8-epi-PGF in plasma, serum, and urine after extraction and purification using a specific immunoassay.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sinzinger H. Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-Areductase inhibitors without CK-elevation? Atherosclerosis 2000; 149: 225–26.

    CAS  Google Scholar 

  2. Sinzinger H, Lupattelli G, Chehne F. Increased lipid peroxidation in a patient with CKelevation and muscle pain during statin therapy. Atherosclerosis 2000; in press.

    Google Scholar 

  3. Holt S, Reeder B, Wilson M, Harvey S, Morrow JD, Roberts LJ H, Moore K. Increased lipid peroxidation in patients with rhabdomyolysis. Lancet 1999; 353: 358–59.

    Google Scholar 

  4. Oguogho A, Mehrabi M, Sinzinger H. Increased plasma, serum and urinary 8-epiprostaglandin FZa in heterozygous hypercholesterolemia. Wiener klin Wochenschr 1999; 111: 113–18.

    CAS  Google Scholar 

  5. Sinzinger H. Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis 1999; 143: 459–60.

    Article  PubMed  CAS  Google Scholar 

  6. Dujovne CA. New lipid lowering drugs and new effects of old drugs. Curr Opin Lipidol 1997; 8: 362–68.

    Article  PubMed  CAS  Google Scholar 

  7. Bliznakov E, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q,0 biosynthesis by lipid-lowering HMG-CoA reductase inhibitors (statins): a critical overview. Adv Therapy 1998; 15: 218–28.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Sinzinger, H., Lupattelli, G., Chehne, F. (2001). Increased Isoprostane 8-epi-PGF2A in Statin-Induced Myopathy. In: Samuelsson, B., Paoletti, R., Folco, G.C., Granström, E., Nicosia, S. (eds) Advances in Prostaglandin and Leukotriene Research. Medical Science Symposia Series, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9721-0_38

Download citation

  • DOI: https://doi.org/10.1007/978-94-015-9721-0_38

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-5881-2

  • Online ISBN: 978-94-015-9721-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics